Foundations and Research Decisions

Foundations and Research Decisions Regarding Susan M. Fitzpatrick's opinion article,1 we agree that many other private foundations have made, and continue to make, important contributions to research on the diseases of the developing world. In fact, we have consulted extensively with several of these foundations during the process of designing the Grand Challenges initiative. We take issue, however, with Dr. Fitzpatrick's claim that the initiative relies "on [National Institutes of Health

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Regarding Susan M. Fitzpatrick's opinion article,1 we agree that many other private foundations have made, and continue to make, important contributions to research on the diseases of the developing world. In fact, we have consulted extensively with several of these foundations during the process of designing the Grand Challenges initiative.

We take issue, however, with Dr. Fitzpatrick's claim that the initiative relies "on [National Institutes of Health] leadership and decision-making." While the initiative is administered by the NIH Foundation, all grant decisions will be made by an independent board of leading scientific experts, including several researchers from the developing world. Of the 20 members of this board, only two or three are part of NIH. In addition, the initiative will be carried out in partnership with other international research institutions as it evolves.

While the Gates Foundation believes strongly in the importance of collaborating with the private sector, governments, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Richard Klausner

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide